(Q34466717)

2 August 2017

1 reference

title

Immunosuppression and bone loss after transplantation (English)

1 reference

2 August 2017

1 reference

Torregrosa JV

1

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

Transplantation Proceedings

2 August 2017

published in

1 reference

2 August 2017

volume

33

1 reference

2 August 2017

issue

7-8

1 reference

2 August 2017

page(s)

3665-3667

1 reference

Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902580-5

7 January 2021

Regulation of bone sialoprotein and osteopontin mRNA expression by dexamethasone and 1,25-dihydroxyvitamin D3 in rat bone organ cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902580-5

7 January 2021

Glucocorticoids inhibit bone resorption by isolated rat osteoclasts by enhancing apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902580-5

7 January 2021

Biochemical, histomorphometric and densitometric changes in patients with multiple myeloma: effects of glucocorticoid therapy and disease activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902580-5

7 January 2021

Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902580-5

7 January 2021

Glucocorticoid decreases circulating osteoprotegerin (OPG): possible mechanism for glucocorticoid induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902580-5

7 January 2021

Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902580-5

7 January 2021

Glucocorticoid osteoporosis--mechanisms and management

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902580-5

7 January 2021

Growth hormone and bone

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902580-5

7 January 2021

Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902580-5

7 January 2021

Rapamycin: a bone sparing immunosuppressant?

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902580-5

7 January 2021

Molecular and functional evidence for calcineurin-A alpha and beta isoforms in the osteoclast: novel insights into cyclosporin A action on bone resorption

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902580-5

7 January 2021

Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902580-5

7 January 2021

Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902580-5

7 January 2021

Bone mineral density after renal transplantation: long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902580-5

7 January 2021

Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902580-5

7 January 2021

Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902580-5

7 January 2021

Mycophenolate mofetil: a promising new immunosuppressant that does not cause bone loss in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902580-5

7 January 2021

Immunosuppressant use without bone loss--implications for bone loss after transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902580-5

7 January 2021

Altered pulsatile gonadotropin signaling in nutritional deficiency in the male

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902580-5

7 January 2021

10.1016/S0041-1345(01)02580-5

Identifiers

DOI

1 reference

2 August 2017

1 reference